Cellceutix Corp Stock Price - CTIX

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$43.59
ULTIMATE TRADER
Monthly Subscription
for only
$65.99
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$30.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cellceutix Corp. (QB) CTIX Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.035 -2.92% 1.165 1.20 1.15 1.20 1.20 16:00:01
Bid Price Ask Price Spread Spread % News
1.16 1.18 0.02 1.69% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
98.00 99,019.00 $ 1.18 $ 116.72k 138.49k 0.95 - 1.92
Last Trade Time Type Quantity Stock Price Currency
15:58:20 1,900.00 $1.17 USD

Cellceutix Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 145.75M 125.11M $ -12.85M - - 87.14M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
666.53k 0.53% $ - 0.00% - -

more financials information »

Cellceutix Corp. (QB) News

Date Time Source News Article
11/15/201606:25Edgar (US Regulatory)Current Report Filing (8-k)
11/09/201606:06Edgar (US Regulatory)Quarterly Report (10-q)
10/28/201617:02Edgar (US Regulatory)Amended Annual Report (10-k/a)
9/15/201608:01Edgar (US Regulatory)Current Report Filing (8-k)
9/13/201608:01Edgar (US Regulatory)Current Report Filing (8-k)
9/13/201606:04Edgar (US Regulatory)Annual Report (10-k)
7/16/201608:00InvestorsHub NewsWireInsider Financial Publishes New Research On Three Promising..

Historical CTIX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.34971.361.150.000090k208k143k-0.18-13.68%
1 Month1.091.5051.070.000029k257k146k0.086.88%
3 Months1.321.5051.070.000029k322k138k-0.16-11.74%
6 Months1.47951.651.070.000029k454k144k-0.31-21.26%
1 Year1.691.920.950.000029k901k182k-0.53-31.07%
3 Years1.444.930.94120.000004M282k-0.28-19.10%
5 Years0.684.930.00010.000004M252k0.4971.32%

Cellceutix Corp. (QB) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161204 14:16:57